 Mark Mennemeier
Concepts (178)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 9 | 2018 | 69 | 2.020 |
Why?
| | Tinnitus | 8 | 2017 | 59 | 1.860 |
Why?
| | Attention | 11 | 2020 | 166 | 1.180 |
Why?
| | Perceptual Disorders | 5 | 2011 | 12 | 0.830 |
Why?
| | Stroke | 5 | 2014 | 478 | 0.820 |
Why?
| | Functional Laterality | 5 | 2012 | 86 | 0.670 |
Why?
| | Reaction Time | 8 | 2017 | 215 | 0.560 |
Why?
| | Temporal Lobe | 3 | 2012 | 70 | 0.530 |
Why?
| | Brain Injuries | 3 | 2014 | 159 | 0.520 |
Why?
| | Peroneal Nerve | 1 | 2014 | 6 | 0.480 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 1 | 2014 | 10 | 0.470 |
Why?
| | Neuropsychological Tests | 4 | 2012 | 336 | 0.460 |
Why?
| | Cold Temperature | 2 | 2011 | 45 | 0.460 |
Why?
| | Patient Admission | 1 | 2014 | 73 | 0.460 |
Why?
| | Size Perception | 2 | 2005 | 3 | 0.460 |
Why?
| | Gait Disorders, Neurologic | 1 | 2014 | 36 | 0.440 |
Why?
| | Positron-Emission Tomography | 4 | 2011 | 286 | 0.420 |
Why?
| | Hypnosis | 1 | 2012 | 6 | 0.410 |
Why?
| | Visual Fields | 4 | 2006 | 36 | 0.370 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2011 | 11 | 0.370 |
Why?
| | Regional Blood Flow | 1 | 2011 | 106 | 0.360 |
Why?
| | Cognition Disorders | 1 | 2011 | 199 | 0.340 |
Why?
| | Adult | 21 | 2020 | 13346 | 0.320 |
Why?
| | Middle Aged | 18 | 2018 | 12285 | 0.320 |
Why?
| | Blood Glucose | 1 | 2011 | 432 | 0.300 |
Why?
| | Orientation | 2 | 2005 | 15 | 0.300 |
Why?
| | Male | 22 | 2018 | 25437 | 0.290 |
Why?
| | Psychomotor Performance | 3 | 2007 | 123 | 0.280 |
Why?
| | Visual Perception | 5 | 2011 | 35 | 0.280 |
Why?
| | Dominance, Cerebral | 2 | 2008 | 21 | 0.280 |
Why?
| | Hospitalization | 1 | 2011 | 663 | 0.270 |
Why?
| | Cross-Over Studies | 5 | 2018 | 223 | 0.270 |
Why?
| | Cerebral Infarction | 1 | 2006 | 36 | 0.260 |
Why?
| | Cognition | 4 | 2018 | 311 | 0.260 |
Why?
| | Female | 20 | 2018 | 26560 | 0.250 |
Why?
| | Aged | 10 | 2018 | 9447 | 0.250 |
Why?
| | Humans | 29 | 2020 | 49898 | 0.250 |
Why?
| | Automobile Driving | 2 | 2002 | 22 | 0.250 |
Why?
| | Brain | 1 | 2012 | 1310 | 0.230 |
Why?
| | Psychophysics | 1 | 2003 | 4 | 0.210 |
Why?
| | Pilot Projects | 4 | 2018 | 702 | 0.210 |
Why?
| | Illusions | 1 | 2002 | 1 | 0.200 |
Why?
| | Vision Disorders | 1 | 2002 | 59 | 0.190 |
Why?
| | Arousal | 4 | 2011 | 98 | 0.190 |
Why?
| | Caffeine | 2 | 2020 | 64 | 0.180 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2020 | 7 | 0.180 |
Why?
| | Central Nervous System Stimulants | 2 | 2020 | 207 | 0.180 |
Why?
| | Hemiplegia | 2 | 2012 | 10 | 0.170 |
Why?
| | Pain Measurement | 2 | 2011 | 246 | 0.160 |
Why?
| | Young Adult | 6 | 2017 | 4029 | 0.150 |
Why?
| | Psychometrics | 2 | 2012 | 226 | 0.150 |
Why?
| | Treatment Outcome | 5 | 2018 | 5176 | 0.150 |
Why?
| | Prefrontal Cortex | 3 | 2013 | 81 | 0.150 |
Why?
| | Alpinia | 1 | 2017 | 1 | 0.150 |
Why?
| | Plant Preparations | 1 | 2017 | 39 | 0.140 |
Why?
| | Apathy | 1 | 2018 | 41 | 0.140 |
Why?
| | Double-Blind Method | 4 | 2020 | 679 | 0.130 |
Why?
| | Sensory Thresholds | 2 | 2013 | 16 | 0.130 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 69 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 550 | 0.120 |
Why?
| | Locomotion | 1 | 2014 | 84 | 0.110 |
Why?
| | Electromyography | 1 | 2014 | 131 | 0.110 |
Why?
| | Biofeedback, Psychology | 1 | 2013 | 17 | 0.110 |
Why?
| | Fiber Optic Technology | 1 | 2013 | 17 | 0.110 |
Why?
| | Research Design | 2 | 2013 | 344 | 0.110 |
Why?
| | Electric Stimulation | 1 | 2013 | 117 | 0.110 |
Why?
| | Anesthetics | 1 | 2013 | 36 | 0.110 |
Why?
| | Visual Acuity | 2 | 2006 | 141 | 0.110 |
Why?
| | Aged, 80 and over | 3 | 2011 | 3136 | 0.100 |
Why?
| | Endoscopy | 1 | 2013 | 118 | 0.100 |
Why?
| | Suggestion | 1 | 2012 | 5 | 0.100 |
Why?
| | Deglutition Disorders | 1 | 2013 | 75 | 0.100 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2011 | 189 | 0.100 |
Why?
| | Adolescent | 5 | 2017 | 6414 | 0.100 |
Why?
| | Language | 1 | 2012 | 134 | 0.090 |
Why?
| | Habituation, Psychophysiologic | 1 | 2011 | 32 | 0.090 |
Why?
| | Radiography | 1 | 2012 | 485 | 0.090 |
Why?
| | Time Factors | 3 | 2013 | 2891 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2006 | 1182 | 0.090 |
Why?
| | Decision Making | 1 | 2013 | 273 | 0.090 |
Why?
| | Foot | 1 | 2011 | 40 | 0.090 |
Why?
| | Home Care Services | 1 | 2011 | 72 | 0.090 |
Why?
| | Feasibility Studies | 2 | 2011 | 382 | 0.090 |
Why?
| | Dementia | 1 | 2011 | 113 | 0.090 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 466 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2011 | 579 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2011 | 552 | 0.080 |
Why?
| | Chronic Disease | 1 | 2012 | 565 | 0.080 |
Why?
| | Smoking | 1 | 2013 | 506 | 0.080 |
Why?
| | Electroencephalography | 1 | 2011 | 304 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 769 | 0.080 |
Why?
| | Equipment Safety | 1 | 2008 | 12 | 0.080 |
Why?
| | Retreatment | 1 | 2008 | 56 | 0.080 |
Why?
| | Secondary Prevention | 1 | 2008 | 78 | 0.080 |
Why?
| | rRNA Operon | 1 | 1997 | 1 | 0.070 |
Why?
| | Mycobacterium | 1 | 1997 | 28 | 0.070 |
Why?
| | Age Factors | 1 | 2011 | 1092 | 0.070 |
Why?
| | Ribosomes | 1 | 1997 | 36 | 0.070 |
Why?
| | Sensation | 1 | 2006 | 12 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2008 | 282 | 0.070 |
Why?
| | Restraint, Physical | 1 | 2006 | 20 | 0.070 |
Why?
| | Reference Values | 1 | 2006 | 302 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 1997 | 467 | 0.060 |
Why?
| | Cues | 1 | 2005 | 48 | 0.060 |
Why?
| | Quality of Life | 1 | 2011 | 837 | 0.060 |
Why?
| | Exercise Therapy | 1 | 2006 | 93 | 0.060 |
Why?
| | Memory | 1 | 2005 | 107 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2017 | 2175 | 0.060 |
Why?
| | Behavior Therapy | 1 | 2006 | 180 | 0.060 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 173 | 0.060 |
Why?
| | Single-Blind Method | 2 | 2013 | 115 | 0.050 |
Why?
| | Space Perception | 1 | 2003 | 11 | 0.050 |
Why?
| | Contrast Sensitivity | 1 | 2002 | 6 | 0.050 |
Why?
| | Fixation, Ocular | 1 | 2002 | 12 | 0.050 |
Why?
| | Models, Psychological | 1 | 2002 | 77 | 0.050 |
Why?
| | Activities of Daily Living | 1 | 2002 | 174 | 0.050 |
Why?
| | Executive Function | 1 | 2018 | 70 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2002 | 1573 | 0.030 |
Why?
| | Sleep | 1 | 2017 | 179 | 0.030 |
Why?
| | Thalamus | 2 | 2006 | 36 | 0.030 |
Why?
| | Anxiety | 1 | 2017 | 273 | 0.030 |
Why?
| | Body Mass Index | 1 | 2017 | 648 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2018 | 283 | 0.030 |
Why?
| | Control Groups | 1 | 2013 | 9 | 0.030 |
Why?
| | Administration, Topical | 1 | 2013 | 56 | 0.030 |
Why?
| | Nose | 1 | 2013 | 31 | 0.030 |
Why?
| | Gambling | 1 | 2013 | 18 | 0.030 |
Why?
| | Deglutition | 1 | 2013 | 40 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 159 | 0.030 |
Why?
| | Impulsive Behavior | 1 | 2013 | 75 | 0.030 |
Why?
| | Reward | 1 | 2013 | 114 | 0.030 |
Why?
| | Choice Behavior | 1 | 2013 | 83 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 1150 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 247 | 0.020 |
Why?
| | Mycobacterium phlei | 1 | 1997 | 1 | 0.020 |
Why?
| | Mycobacterium chelonae | 1 | 1997 | 7 | 0.020 |
Why?
| | Mycobacterium fortuitum | 1 | 1997 | 6 | 0.020 |
Why?
| | RNA, Ribosomal | 1 | 1997 | 20 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1997 | 64 | 0.020 |
Why?
| | RNA, Bacterial | 1 | 1997 | 58 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1997 | 121 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1997 | 189 | 0.020 |
Why?
| | RNA, Ribosomal, 16S | 1 | 1997 | 111 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1997 | 158 | 0.020 |
Why?
| | Plasmids | 1 | 1997 | 164 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1997 | 187 | 0.020 |
Why?
| | Virulence | 1 | 1997 | 171 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 237 | 0.020 |
Why?
| | Molecular Structure | 1 | 1997 | 293 | 0.020 |
Why?
| | Auditory Cortex | 1 | 2006 | 22 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 1997 | 125 | 0.020 |
Why?
| | Therapy, Computer-Assisted | 1 | 2006 | 31 | 0.020 |
Why?
| | Base Sequence | 1 | 1997 | 657 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 456 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 370 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2006 | 35 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1997 | 799 | 0.020 |
Why?
| | Audiometry, Evoked Response | 1 | 2006 | 7 | 0.020 |
Why?
| | Paresis | 1 | 2006 | 6 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1997 | 189 | 0.020 |
Why?
| | Psychological Tests | 1 | 2006 | 49 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2006 | 52 | 0.020 |
Why?
| | Brain Stem | 1 | 2006 | 56 | 0.020 |
Why?
| | Arkansas | 1 | 2011 | 1987 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2006 | 183 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2006 | 204 | 0.020 |
Why?
| | Evoked Potentials, Auditory | 1 | 2006 | 101 | 0.020 |
Why?
| | Benzhydryl Compounds | 1 | 2006 | 66 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2006 | 121 | 0.020 |
Why?
| | Neuroprotective Agents | 1 | 2006 | 100 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2006 | 195 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 907 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2006 | 1128 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2006 | 953 | 0.010 |
Why?
| | Awareness | 1 | 2002 | 28 | 0.010 |
Why?
| | Accidents, Traffic | 1 | 2002 | 87 | 0.010 |
Why?
| | Random Allocation | 1 | 2002 | 285 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 1525 | 0.010 |
Why?
|
|
Mennemeier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|